Key stakeholders and trends within Parkinson's Disease

Your weekly digest, this week with leading stakeholders in the space of Parkinson's Disease. In this post we outline the opinion leaders, rising stars and other key stakeholders as well as publications and trial trends.

Read more

The leaders in Chronic obstructive pulmonary disease (COPD)

COPD is an umbrella term used to describe progressive lung diseases characterized by increasing breathlessness. While there is no cure for the diseas,, gene therapy has become a hot topic for researchers and experts in the search for better treatments and hopefully a cure. In this weeks through the lens we outline the experts, institutions and companies that are moving the needle in this space.

Read more

Positron Emission Tomography – Top experts, top ranked institutions, expert distribution and more in the weekly digest

Your weekly digest of experts in the field of life science research has arrived. Positron emission tomography is a frequently used diagnostic tool for certain brain diseases but also used in research of drug development. The method has a powerful advantage over MRI and x-ray imaging, it can detect biochemical changes before structural changes occur. In this post you will find out more about the expert characteristics, top ranked experts and more.

Read more

Using full-text articles to generate insights for scientific sales and marketing

Many of our customers working in marketing and sales have requested the capability to do full-text searches to understand the market penetration of competing solutions down to the individual researcher level. In this post, we go through a Monocl search for a specific Fluorescent in situ hybridization (FISH) technology to showcase the great power of having full-text content implemented.

Read more

Introducing full-text search

We are very pleased to announce that the Monocl platform now features full-text search of research publications for all applicable stakeholders. This greatly improves your process to identify and prioritize relevant scientific and medical stakeholders based on the research they have performed.

Read more

TYPE II DIABETES & GLP-1 – Top stakeholders, expert characteristics, publication landscape and more in the weekly digest

This week, stakeholder insights brings you type II diabetes and GLP-1 receptor. GLP-1 receptor antagonists are a class of drugs commonly used to treat type II diabetes and has shown promising results in treatment of obesity, making GLP-1 antagonists popular as a second-line treatment in groups of patients who are overweight and obese. You can read more about the expert’s characteristics, top trial sponsors, top ranked experts and more in the weekly digest.

Read more